trending Market Intelligence /marketintelligence/en/news-insights/trending/fxzfikoklmkhmgfm_aw1mq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Guggenheim Securities names senior biotech analyst

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Gauging Supply Chain Risk In Volatile Times


Guggenheim Securities names senior biotech analyst

Michael Schmidt will join Guggenheim Securities in June as a senior analyst and senior managing director as part of the company's expansion of its healthcare research team.

Schmidt will focus on the coverage of biotech companies and will work closely with its therapeutics team.

He has served as an equity research analyst at LEERINK Partners since 2009.

Guggenheim Securities is the investment banking and capital markets division of Guggenheim Partners.